Medical News

RSS

Atlanta Hamilton Medical Center reports zero central line infection

Hospitals in the Atlanta area vary in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 12 Atlanta area hospitals that voluntarily reported their infection rates.

2 Feb 2010

Leapfrog Group urges hospitals to report infection rates for consumers’ benefit

For the first time, in 2009, The Leapfrog Group asked hospitals across the country on behalf of Leapfrog's purchaser members to publicly report their rates of one of the most common and deadly forms of hospital-acquired infections: central-line associated blood stream infections, or CLABSIs.

2 Feb 2010

Central-line bloodstream infections rate vary in San Francisco hospitals

Hospitals in San Francisco vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable.

2 Feb 2010

No Chicago hospital reports zero central line infections

Hospitals in the Chicago area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 15 Chicago hospitals along with other critical patient safety and satisfaction information for consumers.

2 Feb 2010

Infection rates in Boston hospitals vary substantially, says Consumer Reports Health

Hospitals in the Boston area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable.

2 Feb 2010

Hospitals in Houston area vary in terms of how well their ICUs prevent bloodstream infections

Hospitals in the Houston area vary in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable.

2 Feb 2010

Four Detroit area hospitals announce worse than average infection rates

Hospitals in the Detroit area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 25 Detroit area hospitals, along with other critical patient safety and satisfaction information for consumers.

2 Feb 2010

Kool Smiles of Waterbury opened to offer quality dental care

It's all smiles in Waterbury thanks to the new Kool Smiles office, which opened at 728 Wolcott Street, Waterbury, CT in the Fair Oaks Shopping Center. Kool Smiles of Waterbury opened its doors on January 22nd, 2010 in a mission to expand access to quality dental care to families in the community of Waterbury.

2 Feb 2010

New online ratings provide patients with easy access to hospital infection rates

Far too many hospitals expose patients to deadly central-line bloodstream infections despite the availability of a simple life-saving checklist proven to prevent hospital acquired infections, says a new investigative article in the March issue of Consumer Reports.

2 Feb 2010

Four Los Angeles area hospitals report zero central line infections

Hospitals in Los Angeles vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 41 Los Angeles area hospitals, along with other critical patient safety and satisfaction information for consumers.

2 Feb 2010

BC Cancer Foundation's campaign passes significant threshold with major donation for cancer care

Join the BC Cancer Foundation and community leaders for an exciting announcement which will significantly impact the lives of cancer patients and their families throughout Vancouver Island, the Gulf Islands and beyond.

2 Feb 2010

Vantia Therapeutics initiates Phase IIb trial of VA106483 for nocturia

Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, today announces it has begun its planned Phase IIb trial of its lead development compound VA106483 for nocturia.

2 Feb 2010

First Edition: February 2, 2010

Today's health policy headlines focus on highlights of President Obama's fiscal 2011 budget request and how it treats health-related programs. Meanwhile, in the background, health reform chatter continues.

2 Feb 2010

RECOTHROM topical hemostat exhibits low rate of anti-product antibody formation

ZymoGenetics, Inc., today announced the publication of pooled safety and immunogenicity observations from eight clinical trials of RECOTHROM in the February issue of the Journal of the American College of Surgeons. The authors concluded that RECOTHROM is a well-tolerated topical hemostatic agent in numerous surgical settings and has a low rate of anti-product antibody formation. In the pooled data from all trials, less than one percent of treated patients developed product-specific antibodies. None of the antibodies neutralized native coagulation proteins.

2 Feb 2010

Long-term harmful effects of BPA exposure: Cereplast lauds FDA's demand for additional study

Cereplast, Inc., manufacturer of proprietary bio-based sustainable plastics, applauds the Food and Drug Administration (FDA) for demanding increased study of the long-term effects of Bisphenol A (BPA) exposure.

2 Feb 2010

TNS, Lee International sign non-exclusive agreement to distribute TNS’s dietary supplements

Total Nutraceutical Solutions, Inc. (TNS) announced today that the company signed a non-exclusive agreement with Lee International Group Ltd (Lee International) to distribute TNS’s human and veterinary dietary supplements in the S.E Asian markets, including Mainland China.

2 Feb 2010

Cytheris broadens patent protection for recombinant human interleukin-7

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Glycosylated IL-7, Preparation and Uses", US Patent Application Number 11/996,176. The Notice of Allowance is the USPTO’s official communication that the Company’s application has successfully completed examination and that a patent will be issued.

2 Feb 2010

Spectrum Pharmaceuticals signs co-development and commercialization agreement with TopoTarget A/S

Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has entered into a co-development and commercialization agreement with TopoTarget A/S for Belinostat, a novel histone deacetylase (HDAC) inhibitor.

2 Feb 2010

Medco Health Solutions acquires DNA Direct

Committed to being at the forefront of translating personalized medicine from the science to its daily practice in healthcare, Medco Health Solutions, Inc. today announced the acquisition of DNA Direct, Inc., a leader in providing guidance and decision support for genomic medicine to patients, providers, payors and employees.

2 Feb 2010

Global AIDS Alliance calls for Congress to fully fund the Global Health Initiative

President Obama's budget, transmitted to Congress this morning, includes $8.5 billion for a Global Health Initiative. Based on projections to continue supporting robust U.S. programs to fight AIDS, TB and malaria and implement GHI priorities -- $16.4 billion is required in FY2011.

2 Feb 2010

Medical News

Atlanta Hamilton Medical Center reports zero central line infection

Leapfrog Group urges hospitals to report infection rates for consumers’ benefit

Central-line bloodstream infections rate vary in San Francisco hospitals

No Chicago hospital reports zero central line infections

Infection rates in Boston hospitals vary substantially, says Consumer Reports Health

Hospitals in Houston area vary in terms of how well their ICUs prevent bloodstream infections

Four Detroit area hospitals announce worse than average infection rates

Kool Smiles of Waterbury opened to offer quality dental care

New online ratings provide patients with easy access to hospital infection rates

Four Los Angeles area hospitals report zero central line infections

BC Cancer Foundation's campaign passes significant threshold with major donation for cancer care

Vantia Therapeutics initiates Phase IIb trial of VA106483 for nocturia

First Edition: February 2, 2010

RECOTHROM topical hemostat exhibits low rate of anti-product antibody formation

Long-term harmful effects of BPA exposure: Cereplast lauds FDA's demand for additional study

TNS, Lee International sign non-exclusive agreement to distribute TNS’s dietary supplements

Cytheris broadens patent protection for recombinant human interleukin-7

Spectrum Pharmaceuticals signs co-development and commercialization agreement with TopoTarget A/S

Medco Health Solutions acquires DNA Direct

Global AIDS Alliance calls for Congress to fully fund the Global Health Initiative

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News